Sionex announces a strategic investment and development agreement with In-Q-Tel, a private venture group funded by the Central Intelligence Agency (CIA) and the US intelligence community
"This agreement with In-Q-Tel is a tremendous validation of Sionex's technology and its significance for realizing the vast potential of cutting-edge detection technology for chemicals and biological materials," said Wes Davis, president and CEO of Sionex.
"In-Q-Tel's investment will allow Sionex to continue leading the next wave of the detection revolution." This new investment capital will be used to support both commercial market and technical development efforts.
It will also enable Sionex to provide additional support to its major customers in the government, environmental, diagnostics and industrial sectors.
"Sionex has developed a revolutionary biological and chemical sensing platform that is highly applicable to a wide range of commercial and government markets," said Amit Yoran, president and CEO of In-Q-Tel.
"Sionex's unique capabilities have the potential to bring about a paradigm shift in detection systems, enabling the sensing of compounds on an unparalleled scale with unprecedented sensitivity and selectivity."
